COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years.
New Delhi: COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. While addressing a press conference, Dr. VK Paul, Member-Health, Niti Aayog said, “I have been told that trials will begin in the next 10-12 days
Source :
